This is what Big Pharma greed looks like!
Congress
A new report finds that the 14 leading drug corporations spent $577 billion on stock buybacks and dividends between 2016 and 2020. That’s how greedy Big Pharma is.
This House Oversight Committee report destroys the phony narrative of Big Pharma’s “innovation” as a justification for its sky-high prices.
Let’s be clear: between 2016 and 2020, Big Pharma spent $56 billion MORE on buybacks and dividends than it spent on R&D!
Sponsored by
.png)
To:
Congress
From:
[Your Name]
This House Oversight Committee report is a damning indictment of Big Pharma’s greed. This is why Medicare must be able to negotiate drug prices!